STAT

FDA and NIH let clinical trial sponsors keep results secret, investigation shows

A Science investigation shows that many clinical trial sponsors still ignore the requirement to report results, while federal officials do little to enforce the law.

This story was originally published by Science. It is a follow-up to STAT articles in 2015 and 2018 on the failure of many clinical trial sponsors to report results to ClinicalTrials.gov.

For 20 years, the U.S. government has urged companies, universities, and other institutions that conduct clinical trials to record their results in a federal database, so doctors and patients can see whether new treatments are safe and effective. Few trial sponsors have consistently done so, even after a 2007 law made posting mandatory for many trials registered in the database. In 2017, the National Institutes of Health and the Food and Drug Administration tried again, enacting a long-awaited “final rule” to clarify the law’s expectations and penalties for failing to disclose trial results.

The rule took full effect two years ago, on Jan. 18, 2018, giving trial sponsors ample time to

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related